Authors
Latest:
ASD and Medication Adherence: An Opportunity for Pharmacist InterventionUnfortunately, medication adherence in children with ASD is poor, particularly among children with chronic conditions or comorbid mental health conditions.
Latest:
Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost TrendsBased on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
Latest:
Leveraging Immunization Information Systems: Emerging Data Sources to Drive Vaccination RatesPharmacists are changing the face of public health, and the nation’s thought leaders have taken notice.
Latest:
Prescriptions at Independent Pharmacies: Slow or No GrowthIndependent retail pharmacies can thrive in today's competitive market-if owners commit to changing their business models.
Latest:
Telephone-Based Cardiovascular Medication Therapy Management in Medicare Part D Enrollees With DiabetesA telephonic pharmacist-delivered medication therapy management intervention is an effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk Medicare patients with diabetes.
Latest:
Get PrEPared for HIV ProphylaxisExpansion to adolescents, flexible dosing strategies, innovative delivery models, and long-acting antiretrovirals all help the strategy.
Latest:
Demographic Characteristics of Asthma Subjects Associated With Stepping Down From Fluticasone Propionate/Salmeterol Combination TherapyPatients on fluticasone propionate/salmeterol maintenance therapy who have more frequent physician interactions, especially interactions with asthma specialists, may be more likely have their controller medication reduced.
Latest:
Claims Data Analysis of Dosing and Cost of TNF AntagonistHigher drug costs may be attributable to either high initial doses or a dose increase.
Latest:
Evaluating and Elevating Specialty Pharmacists Through CertificationThe development of the Certified Specialty Pharmacist provides the opportunity for specialty pharmacists to demonstrate their expertise through an evaluation of their skills.
Latest:
The Ups and Downs of the Elevator SpeechIn today’s job market, it is crucial that you equip yourself with the tools you need to find a position.
Latest:
THE PHARMACEUTICAL INDUSTRY: CONTRIBUTING TO BETTER MEDICINESDrs. Patel, Singh, and Whalen are postdoctoral fellows in the Rutgers Pharmaceutical Industry Fellowship Program. Dr. Alexander is director of the Institute for Pharmaceutical Industry Fellowships, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. Dr. Barone is professor and chair of the Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey.
Latest:
3 Words Nobody Should Say in the PharmacyEach day you encounter patients with multiple and various disease states, alignments, and questions. For some, questions they initially didn’t think they even had.
Latest:
Taking on AMCP Nexus: A First-Time Conference ExperienceAs one of Academy of Managed Care Pharmacy’s two annual conventions, AMCP Nexus aims to provide in-depth educational programming on the current advances and challenges in managed care.
Latest:
Status Epilepticus: When Benzodiazepine Fails to Elicit ResponseSE requires prompt intervention to terminate seizure activity to prevent neuronal damage and complications.
Latest:
Prescription Drug Adherence: A "Challenge" for So Many…Poor medication compliance in chronic diseases in a well-known public health problem. Pharmacists play a key role in optimizing medication use in patients with chronic conditions.
Latest:
No Simple Answers for Lowering Drug CostsAlthough there is a persistent need for lower prescription drug costs, this simple concept is complicated by multiple factors.
Latest:
Health System Specialty Pharmacy: Benefits to Oncology Prescription Turnaround TimesPrior authorization (PA) requirements, cost, and other factors can lead to turnaround times of up to 3 weeks, delaying the start of therapy and creating substantial anxiety for patients.
Latest:
Monday Pharmaceutical Mystery: How Did Getting Healthy and Losing Weight Result in Kidney Failure?RG is a male patient aged 45 years who has arrived at the pharmacy to pick up his regular maintenance medications after recently losing 45 pounds in 3 months.
Latest:
Consistency Is Vital When Conducting Internal InvestigationsMake sure that all individuals involved are exposed to the same process and treated equally, even though the infractions may differ.
Latest:
Will a New Utah Law Change the DIR Conversation?Although there has been an increasing amount of legislation regarding it, as well, the Utah legislature has taken a very different approach.
Latest:
Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty PracticeWhile warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.
Latest:
Pharmacist Management of Alpelisib-Associated HyperglycemiaThe selection of an agent for hyperglycemia management requires knowledge of both the efficacy and the potential adverse effects of each possible agent, so choosing the best therapy for any given patient can be complicated.
Latest:
FDA Adds Novel Antimicrobials to ArsenalAntimicrobial resistance continues to pose a significant health threat, necessitating new antibiotics with novel mechanisms to treat these complicated infections. However, between 2010 and 2018, newly approved antibiotics were primarily derived from previously established drug classes. This past summer, the FDA approved 2 new antibiotics.
Latest:
Effectiveness and Costs of Biologics in Veterans With Rheumatoid ArthritisThis study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
